Suppr超能文献

医学上重要细菌感染的分子诊断

Molecular diagnostics of medically important bacterial infections.

作者信息

Millar Beverley Cherie, Xu Jiru, Moore John Edmund

机构信息

Northern Ireland Public Health Laboratory, Department of Bacteriology, Belfast City Hospital, Belfast, Northern Ireland, BT9 7AD, UK.

出版信息

Curr Issues Mol Biol. 2007 Jan;9(1):21-39.

Abstract

Infectious diseases are common diseases all over the world. A recent World Health Organization report indicated that infectious diseases are now the world's biggest killer of children and young adults. Infectious diseases in non-industrialized countries caused 45% in all and 63% of death in early childhood. In developed countries, the emergence of new, rare or already-forgotten infectious diseases, such as HIV/AIDS, Lyme disease and tuberculosis, has stimulated public interest and inspired commitments to surveillance and control. Recently, it is reported that infectious diseases are responsible for more than 17 million deaths worldwide each year, most of which are associated with bacterial infections. Hence, the control of infectious diseases control is still an important task in the world. The ability to control such bacterial infections is largely dependent on the ability to detect these aetiological agents in the clinical microbiology laboratory. Diagnostic medical bacteriology consists of two main components namely identification and typing. Molecular biology has the potential to revolutionise the way in which diagnostic tests are delivered in order to optimise care of the infected patient, whether they occur in hospital or in the community. Since the discovery of PCR in the late 1980s, there has been an enormous amount of research performed which has enabled the introduction of molecular tests to several areas of routine clinical microbiology. Molecular biology techniques continue to evolve rapidly, so it has been problematic for many laboratories to decide upon which test to introduce before that technology becomes outdated. However the vast majority of diagnostic clinical bacteriology laboratories do not currently employ any form of molecular diagnostics but the use such technology is becoming more widespread in both specialized regional laboratories as well as in national reference laboratories. Presently molecular biology offers a wide repertoire of techniques and permutations of these analytical tools, hence this article wishes to explore the application of these in the diagnostic laboratory setting.

摘要

传染病是全球常见的疾病。世界卫生组织最近的一份报告指出,传染病目前是全球儿童和年轻人的最大杀手。在非工业化国家,传染病导致的死亡占总数的45%,在幼儿中占63%。在发达国家,新出现的、罕见的或已被遗忘的传染病,如艾滋病毒/艾滋病、莱姆病和结核病的出现,激发了公众的兴趣,并促使人们致力于监测和控制。最近有报道称,传染病每年在全球造成超过1700万人死亡,其中大部分与细菌感染有关。因此,控制传染病仍然是全球的一项重要任务。控制此类细菌感染的能力在很大程度上取决于临床微生物实验室检测这些病原体的能力。诊断医学细菌学主要由两个部分组成,即鉴定和分型。分子生物学有可能彻底改变诊断测试的方式,以便优化对感染患者的护理,无论他们是在医院还是在社区感染。自20世纪80年代末发现聚合酶链反应(PCR)以来,已经进行了大量的研究,使得分子检测能够引入常规临床微生物学的多个领域。分子生物学技术持续快速发展,因此对于许多实验室来说,在技术过时之前决定引入哪种检测一直是个难题。然而,绝大多数诊断临床细菌学实验室目前并未采用任何形式的分子诊断方法,但这种技术在专业区域实验室和国家参考实验室中越来越普遍。目前分子生物学提供了广泛的技术和这些分析工具的排列组合,因此本文希望探讨这些技术在诊断实验室环境中的应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验